Related Experiment Video
Updated: Aug 8, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
[Developing Biomarkers in Precision Medicine for Asthma and COPD]
1Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka.
Precision medicine tailors treatments for chronic respiratory diseases like asthma and COPD by analyzing patient phenotypes and endotypes. Biomarkers are key to identifying optimal treatments for conditions like asthma-COPD overlap.
Area of Science:
- Pulmonology and Respiratory Medicine
- Translational Medicine
- Biomarker Discovery
Context:
- The limitations of 'one-size-fits-all' treatments for heterogeneous chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD).
- The increasing demand for precision medicine approaches tailored to individual patient characteristics.
- The need to integrate phenotypic and endotypic information for effective disease management.
Purpose:
- To investigate a precision medicine strategy for asthma-COPD overlap (ACO).
- To identify biomarkers for stratifying treatment in patients with COPD and asthma.
- To explore the potential of blood proteins and microRNAs as diagnostic and therapeutic indicators in ACO.
Summary:
- This study focused on identifying patients with COPD who could benefit from asthma medications and characterizing the pathology of asthma-COPD overlap (ACO).
- Researchers conducted clinical and basic studies to uncover specific pathological features of ACO.
- Several blood proteins and microRNAs were identified as potential biomarkers for customizing treatment strategies in ACO patients.
Impact:
- Highlights the potential of a treatable-traits approach in precision medicine for respiratory diseases.
- Provides a foundation for developing novel biomarkers to personalize treatment for asthma-COPD overlap.
- Aims to improve clinical outcomes by enabling more targeted and effective therapeutic interventions.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

